lobbying_activities: 2149486

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2149486	b6f0318f-7a57-4f87-a1c5-92ea2d627199	Q2	SPLITOAK STRATEGIES LLC	401104582	CARIS SCIENCE INC	2018	second_quarter	MED	FDA oversight of Next Generation Sequencing technology for advanced cancers. Medicare coverage of Next Generation Sequencing technology for advanced cancers. Finalize PAMA reform of Medicare clinical lab payments.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2018-07-18T10:58:20.507000-04:00